HLB bioStep Co.,Ltd. (KOSDAQ: 278650)

HLB bioStep Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	37,267	68,799	14,873	6,158	8,040	5,202
Short-Term Investments	1,684	1,578	55,000	-	2,550	11,000
Trading Asset Securities	1,453	-	27,191	4,235	4,320	-
Cash & Short-Term Investments	40,403	70,377	97,064	10,393	14,910	16,202
Cash Growth	-55.83%	-27.49%	833.97%	-30.30%	-7.98%	322.08%
Accounts Receivable	5,211	3,730	7,009	7,788	6,800	4,449
Other Receivables	467.02	337.14	2,738	662.43	580.36	2,114
Receivables	6,060	4,469	10,065	10,153	8,829	6,946
Inventory	1,427	1,551	1,650	2,920	2,341	1,098
Prepaid Expenses	-	249	133.97	10.39	8.75	9.62
Other Current Assets	5,390	2,767	512.37	5,520	2,490	4,973
Total Current Assets	53,279	79,413	109,426	28,996	28,579	29,228
Property, Plant & Equipment	54,457	40,678	39,626	39,867	26,226	23,146
Long-Term Investments	43,690	44,916	12,811	15,051	12,287	2,665
Goodwill	6,372	1,049	1,049	1,253	1,253	1,253
Other Intangible Assets	3,838	750.69	811.65	722.08	643.24	74.25
Long-Term Deferred Tax Assets	-	1,096	2,127	1,302	912.09	1,089
Other Long-Term Assets	8,375	2,841	6,316	7,414	3,495	2,726
Total Assets	170,981	171,714	172,187	94,626	74,215	61,531
Accounts Payable	1,222	1,573	2,050	1,648	1,356	1,369
Accrued Expenses	634.44	438.93	533.51	324.38	282.67	214.14
Short-Term Debt	25,443	54,316	1,689	1,189	210	210
Current Portion of Long-Term Debt	6,748	3,448	3,224	3,000	3,000	-
Current Portion of Leases	610.58	367.28	398.72	841.66	696.08	405.16
Current Income Taxes Payable	-	19.77	352.86	1,444	674.94	531.27
Other Current Liabilities	11,522	4,518	4,527	8,134	9,159	8,013
Total Current Liabilities	46,180	64,682	12,775	16,582	15,379	10,742
Long-Term Debt	1,793	2,017	85,911	10,690	2,690	5,690
Long-Term Leases	1,015	487.93	418.11	583	910.01	568
Other Long-Term Liabilities	1,392	643.61	753.88	151.03	28.07	10.69
Total Liabilities	51,734	68,141	99,984	28,265	19,191	17,161
Common Stock	8,673	7,863	7,053	765.19	761.94	731.7
Additional Paid-In Capital	86,299	60,104	31,827	29,661	28,608	25,477
Retained Earnings	25,510	30,727	31,366	34,476	24,585	15,977
Treasury Stock	-7,332	-1,422	-	-	-960.15	-
Comprensive Income & Other	2,019	4,318	30.94	-315.38	648.22	-321.39
Total Common Equity	115,169	101,590	70,278	64,587	53,643	41,864
Minority Interest	4,079	1,983	1,925	1,774	1,381	1,159
Shareholders' Equity	119,247	103,573	72,202	66,361	55,024	44,370
Total Liabilities & Equity	170,981	171,714	172,187	94,626	74,215	61,531
Total Debt	35,610	60,637	91,641	16,304	7,506	6,873
Net Cash (Debt)	4,794	9,740	5,424	-5,911	7,404	9,329
Net Cash Growth	-80.42%	79.57%	-	-	-20.64%	-
Net Cash Per Share	61.26	126.96	77.48	-84.46	107.21	153.35
Filing Date Shares Outstanding	84.2	78.13	70.53	68.87	67.93	65.85
Total Common Shares Outstanding	84.2	78.13	70.53	68.87	68.57	65.85
Working Capital	7,100	14,731	96,651	12,414	13,200	18,486
Book Value Per Share	1367.87	1300.35	996.42	937.86	782.27	635.71
Tangible Book Value	104,959	99,790	68,417	62,612	51,747	40,536
Tangible Book Value Per Share	1246.61	1277.31	970.03	909.17	754.61	615.55
Land	27,576	15,253	15,253	13,417	9,744	9,744
Buildings	30,805	24,974	24,280	23,327	12,312	11,880
Construction In Progress	56.8	989.4	-	511.28	2,631	-

Source: S&P Capital IQ. Standard template. Financial Sources.